MAUREEN DUKE: Open Payments
NPI 1760577530 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,362 in 109 payments from 19 companies in 2025. Trend: 2023 $2,079 · 2024 $2,100 · 2025 $2,362
Food & beverage: $2,340Consulting: $21
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 24 | $480 |
| GENZYME CORPORATION | 12 | $325 |
| GlaxoSmithKline, LLC. | 17 | $269 |
| Regeneron Healthcare Solutions, Inc. | 9 | $200 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $196 |
| Grifols USA, LLC | 7 | $185 |
| CSL Behring | 6 | $149 |
| Amgen Inc. | 5 | $87 |
| BioCryst US Sales Co., LLC | 3 | $85 |
| Novartis Pharmaceuticals Corporation | 3 | $83 |
Products named: DUPIXENT, TEZSPIRE, AIRSUPRA, TRELEGY ELLIPTA, Xembify, CUVITRU, Xolair, ORLADEYO.
Industry payments across PA — which companies pay providers there.
